Preview

Current Pediatrics

Advanced search

3-Methylglutaconic Aciduria Type VIIB — Rare Hereditary Metabolic Disorder with Antenatal Onset: Clinical Case

https://doi.org/10.15690/vsp.v24i2.2892

Abstract

Background. 3-methylglutaconic aciduria (3-MGA), type VIIB is a rare hereditary disease with onset in the antenatal period, extremely severe course, and unfavorable outcome. This form of aciduria has not been previously described in Russian Federation. Clinical case description. Severe neonatal 3-MGA caused by pathogenic allele in the CLPB gene manifested in a newborn child with non-epileptic motor disorders (tremor, myoclonus) along with seizures resistant to therapy, and severe neutropenia. Bacterial infection with pneumonia and chylothorax development was observed. The specific feature of this case is the absence of cataract typical for 3-MGA, type VIIB, but presence of hypoparathyroidism, that was not previously described as the manifestations of this disease. Diagnosis 3-MGA, type VIIB, was confirmed by whole-genome sequencing. Two variants of the CLPB gene (NM_001258392.3) were revealed: HG38 variant (chr11-72301838C>CT, c.1293dup) in heterozygous state leading to frameshift and premature stop codon (p.Asp432Argfs*11), and novel HG38 variant (chr11-72294617T>TA, c.1560+2dup) in heterozygous state leading to changes in splice donors. The child died at the age of 1 month and 6 days despite intensive multicomponent management. Conclusion. Pathological motor activity of the intrauterine child combined with neonatal motor impairment and neutropenia are sufficient basis for whole-genome sequencing to establish etiological diagnosis. The types of 3-MGA inheritance correlate with different disease prognosis, thus, it is crucial to examine proband’s parents to evaluate the risks of sick children birth.

About the Authors

Irina A. Belyaeva
Morozovskaya Children’s City Hospital; Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
Russian Federation

Moscow


Disclosure of interest:

Irina A. Belyaeva — lecturing for pharmaceutical companies Progress, Bayer, AstraZeneca, Abbott Laboratories, Hero Rus, SVITMILK



Anna L. Karpova
City Clinical Hospital No. 67 named after L.A. Vorokhobov; Russian Medical Academy of Continuing Professional Education; Yaroslavl State Medical University
Russian Federation

Moscow; Yaroslavl


Disclosure of interest:

Ather authors confirmed the absence of a reportable conflict of interests



Maria G. Degtyareva
Pirogov Russian National Research Medical University
Russian Federation

Moscow


Disclosure of interest:

Ather authors confirmed the absence of a reportable conflict of interests



Andrey Yu. Kruglyakov
Morozovskaya Children’s City Hospital
Russian Federation

Moscow


Disclosure of interest:

Ather authors confirmed the absence of a reportable conflict of interests



Mikhail M. Kamenev
Morozovskaya Children’s City Hospital
Russian Federation

Moscow


Disclosure of interest:

Ather authors confirmed the absence of a reportable conflict of interests



Tatyana A. Tenovskaya
Morozovskaya Children’s City Hospital
Russian Federation

Moscow


Disclosure of interest:

Ather authors confirmed the absence of a reportable conflict of interests



Anastasiya V. Sheremetyeva
Morozovskaya Children’s City Hospital; Peoples’ Friendship University of Russia
Russian Federation

Moscow


Disclosure of interest:

Ather authors confirmed the absence of a reportable conflict of interests



References

1. Flora V. Glavnyi neonatolog Minzdrava rasskazal, chem chashche vsego boleyut rossiiskie mladentsy. Rossiiskaya Federatsiya segodnya. 2023;(4):82–85. (In Russ).

2. Ling SY, Yu Y, Qiu WJ, et al. Analysis of six children with 3-methylglutaconic aciduria. Zhonghua Er Ke Za Zhi. 2021;59(8):695–699. doi: https://doi.org/10.3760/cma.j.cn112140-20210202-00094

3. Itonaga T, Maeda M, Koga H, et al. Asymptomatic 3-methylglutaconic aciduria type 1 detected by high C5-OH on newborn screening. Mol Genet Metab Rep. 2023;38:101024. doi: https://doi.org/10.1016/j.ymgmr.2023.101024

4. Bizjak N, Zerjav Tansek M, Avbelj Stefanija M, et al. Precocious puberty in a girl with 3-methylglutaconic aciduria type 1 (3-MGA-I) due to a novel AUH gene mutation. Mol Genet Metab Rep. 2020;25:100691. doi: https://doi.org/10.1016/j.ymgmr.2020.100691

5. Nardecchia F, Caciotti A, Giovanniello T, et al. 3-Methylglutaconic Aciduria Type I Due to AUH Defect: The Case Report of a Diagnostic Odyssey and a Review of the Literature. Int J Mol Sci. 2022;23(8):4422. doi: https://doi.org/10.3390/ijms23084422

6. #616271. 3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB. In: OMIM — Online Mendelian Inheritance in Man: Official website. Available online: https://omim.org/entry/616271. Accessed on January 14, 2025.

7. Wortmann SB, Ziętkiewicz S, Kousi M, et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet. 2015;96(2):245–257. doi: https://doi.org/10.1016/j.ajhg.2014.12.013

8. 3-Methylglutaconic Aciduria Overview. Genetic and Rare Diseases Information Center. In: GARD — Genetic and Rare Diseases Information Center: Official website. Available online: https://rarediseases.info.nih.gov/diseases/17767/x. Accessed on January 14, 2025.

9. Pronicka E, Ropacka-Lesiak M, Trubicka J, et al. A scoring system predicting the clinical course of CLPB defect based on the foetal and neonatal presentation of 31 patients. J Inherit Metab Dis. 2017;40(6):853–860. doi: https://doi.org/10.1007/s10545-017-0057-z

10. Wortmann SB, Wevers RA. CLPB Deficiency. In: GeneReviews® [Internet]. Adam MP, Feldman J, Mirzaa GM, et al., eds. Seattle (WA): University of Washington, Seattle; 1993–2025. Available online: https://www.ncbi.nlm.nih.gov/books/NBK396257. Accessed on January 14, 2025.

11. Kanabus M, Shahni R, Saldanha JW, et al. Bi-allelic CLPB mutations cause cataract, renal cysts, nephrocalcinosis and 3-methylglutaconic aciduria, a novel disorder of mitochondrial protein disaggregation. J Inherit Metab Dis. 2015;38(2):211–219. doi: https://doi.org/10.1007/s10545-015-9813-0

12. Karpova AL, Narogan MV, Mostovoy AV, et al. Umbilical cord blood glucose levels in full-term newborns. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2014;59(2):54–56. (In Russ).

13. 3-Methylglutaconic Aciduria Type VII. In: Orphanet. Available online: https://www.orpha.net/en/disease/detail/445038?name=%23%20616271&mode=omim. Accessed on January 14, 2025.

14. Jones DE, Klacking E, Ryan RO. Inborn errors of metabolism associated with 3-methylglutaconic aciduria. Clin Chim Acta. 2021;522:96–104. doi: https://doi.org/10.1016/j.cca.2021.08.016

15. Gamisoniya A. 3-metilglutakonovaya atsiduriya tip I. Genokarta: geneticheskaya entsiklopediya: Official website.

16. Gamisoniya A. 3-metilglutakonovaya atsiduriya tip V. Genokarta: geneticheskaya entsiklopediya: Official website.

17. Rivalta B, Torraco A, Martinelli D, et al. Biallelic CLPB mutation associated with isolated neutropenia and 3-MGA-uria. Pediatr Allergy Immunol. 2022;33(5):e13782. doi: https://doi.org/10.1111/pai.13782

18. Wortmann SB, Ziętkiewicz S, Guerrero-Castillo S, et al. Neutropenia and intellectual disability are hallmarks of biallelic and de novo CLPB deficiency. Genet Med. 2021;23(9):1705–1714. doi: https://doi.org/10.1038/s41436-021-01194-x

19. Capo-Chichi JM, Boissel S, Brustein E, et al. Disruption of CLPB is associated with congenital microcephaly, severe encephalopathy and 3-methylglutaconic aciduria. J Med Genet. 2015;52(5): 303–311. doi: https://doi.org/10.1136/jmedgenet-2014-102952

20. Huang Z, Liu Y, Huang X, et al. Newborn screening for 3-hydroxy-3-methylglutaric aciduria using direct analysis in realtime mass spectrometry. J Mass Spectrom. 2019;54(2):134–140. doi: https://doi.org/10.1002/jms.4314

21. Wanders RJ, Schutgens RB, Zoeters BH. Prenatal diagnosis of 3-hydroxy-3-methylglutaric aciduria via enzyme activity measurements in chorionic villi, chorionic villous fibroblasts or amniocytes using a simple spectrophotometric method. J Inherit Metab Dis. 1988;11(4):430. doi: https://doi.org/10.1007/BF01800436


Review

For citations:


Belyaeva I.A., Karpova A.L., Degtyareva M.G., Kruglyakov A.Yu., Kamenev M.M., Tenovskaya T.A., Sheremetyeva A.V. 3-Methylglutaconic Aciduria Type VIIB — Rare Hereditary Metabolic Disorder with Antenatal Onset: Clinical Case. Current Pediatrics. 2025;24(2):96-104. (In Russ.) https://doi.org/10.15690/vsp.v24i2.2892

Views: 130


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)